Skip to content

Gut Microbiota-Derived β-Glucuronidase Governs the Anticolitic Efficacy of Daidzein via the ERβ-PI3K/Akt/mTOR-Autophagy Axis.

Oct 2026 · Journal of Agricultural and Food Chemistry · Vol 74 43, pp. 33950-33962 · 0 citations · 40 references
Medicine

TL;DR

Findings unveil a potential Microbiota-GUS-ERβ-PI3K/Akt/mTOR-autophagy mechanistic axis, establishing a robust theoretical foundation for precision nutritional strategies targeting specific gut microbiota.

Abstract

Precision nutritional interventions targeting the gut microenvironment have emerged as a pivotal strategy for managing inflammatory bowel disease (IBD). However, the specific microbial mechanisms governing the therapeutic efficacy of dietary flavonoids, such as daidzein (DA), remain largely unexplored. In this study, it was observed that administration of 40 mg/kg DA significantly attenuated DSS-induced colitis, preserving mucosal barrier integrity and suppressing inflammation. Multiomics analysis revealed that DA reprogrammed the gut microbiota composition, specifically enriching β-glucuronidase (GUS)-producing bacteria, especially Bacteroides thetaiotaomicron. Mechanistically, the effects of microbially bioactivated DA were associated with host estrogen receptor beta (ERβ) signaling. Pharmacological blockade further supported the involvement of ERβ signaling in the suppression of PI3K/Akt/mTOR signaling and restoration of autophagy, thereby contributing to intestinal epithelial repair. Collectively, these findings unveil a potential Microbiota-GUS-ERβ-PI3K/Akt/mTOR-autophagy mechanistic axis, establishing a robust theoretical foundation for precision nutritional strategies targeting specific gut microbiota.

View source

Similar papers

Open access Oct 2026

Gut Microbiota‐Dependent Tryptophan Metabolism Drives the Therapeutic Effects of Baitouweng Tang in Colitis via the AhR Pathway

ABSTRACT With dysregulation of the gut microbiota and its metabolic byproducts playing a pivotal role in inflammatory bowel disease (IBD) pathogenesis. Baitouweng Tang (BTWT), a traditional herbal formulation, has long been employed to treat gastrointestinal disorders and shows promising potential in the management of...

Chun Niu, Yong-Li Hua, Jian-Guo Kang et al. · 0 citations
Oct 2026

Jaceosidin, a Natural Flavonoid From Artemisia argyi, Alleviates Colitis by Remodeling Gut Microbiota to Promote Treg Differentiation via the 5‐HIAA‐AhR Axis

JAC alleviates experimental colitis in association with microbiota remodeling and increased fecal 5‐HIAA, and exogenous 5‐HIAA shows anti‐colitis and Treg‐promoting activity, supporting further investigation of its contribution to JAC efficacy.

Jing-Jing Yang, Ren-Jie Zhou, Xue-Ning Jiang et al. · 0 citations
Open access Nov 2026

Polysaccharides from Hericium erinaceus mitigate diet-induced obesity by modulating hepatic AMPK signaling and restoring intestinal barrier function via gut microbiota remodeling

Obesity pathogenesis involves a multifaceted interplay between systemic metabolic dysregulation and intestinal microbiota dysbiosis. Using a high-fat diet (HFD)-induced obese mouse model, this research aimed to elucidate the anti-obesity effects and metabolic regulatory functions of Hericium erinaceus polysaccharid...

Jia-Cheng Ye, Mei-Qun Ye, Xue Zhou et al. · 0 citations
Oct 2026

Forsythiae Fructus polysaccharides mitigate DSS colitis by modulating gut microbiota-derived palmitic acid and PI3K/AKT pathway.

Inflammatory bowel disease (IBD) is a chronic inflammatory disorder with limited therapeutic options, and the contribution of microbiota-associated metabolites to disease progression remains incompletely understood. Here, we demonstrate that Forsythia polysaccharides (FPs) exert protective effects against dextran sulfa...

Peng Cheng, Ying Huang, Yi-Xiang Luo et al. · 0 citations
Open access Oct 2026

Baicalin and levofloxacin exert divergent modulation on gut microbiota and metabolome crosstalk in DSS-triggered ulcerative colitis

ABSTRACT Baicalin (BA), a bioactive flavonoid, and levofloxacin hydrochloride (LH), a fluoroquinolone antibiotic, both hold potential for ulcerative colitis (UC) treatment, yet the mechanistic differences in their regulation of gut microbiota and metabolome remain elusive. This study aimed to systematically compare the...

Cai-Xia Wang, Wei-Han Wu, Ming Cui et al. · 0 citations
Open access Oct 2026

Live combined bifidobacterium attenuates rivaroxaban-associated colonic bleeding in mice: evidence for a substantial gut microbiota-dependent component

Rivaroxaban, a direct oral anticoagulant (DOAC), is widely prescribed for the prevention and treatment of thromboembolic disorders. However, its use is associated with an increased risk of gastrointestinal bleeding, the mechanisms of which remain incompletely understood. Effective strategies to relief such bleeding are...

Xiao-Wen Chen, Yu-Ze Lin, You-Qi Huang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.